The Ed.
Well-Known Member
Recent research looking into curing alopecia appears to have been successful. Alopecia areata is a devastating condition that can cause severe, patchy baldness that is difficult to treat. Alopecia areata affects around two in every 1,000 people in the UK and is thought to be caused by the immune system attacking hair follicles.
Now thought, scientists have completely reversed hair loss in three people by giving them a drug normally used to treat bone marrow disorders. Three sufferers of the disease were treated twice daily with a dose of ruxolitinib - a drug already approved in the EU and USA for bone marrow conditions. In all three case, the alopecia areata had been completely reversed within five months.
Lead researcher Dr Raphael Clynes said, "We've only begun testing the drug in patients, but if the drug continues to be successful and safe, it will have a dramatic positive impact on the lives of people with the disease."
Prof David Bickers, a dermatologist at Columbia University who has treated many patients with the disease, said, "There are few tools in the arsenal for the treatment of alopecia areata that have any demonstrated efficacy.
"This is a major step forward in improving the standard of care for patients suffering from this devastating disease."
The results of the trials, conducted at Columbia University Medical Center, have been published in the journal Nature Medicine.
Until then...geek on!
The Ed.
Now thought, scientists have completely reversed hair loss in three people by giving them a drug normally used to treat bone marrow disorders. Three sufferers of the disease were treated twice daily with a dose of ruxolitinib - a drug already approved in the EU and USA for bone marrow conditions. In all three case, the alopecia areata had been completely reversed within five months.
Lead researcher Dr Raphael Clynes said, "We've only begun testing the drug in patients, but if the drug continues to be successful and safe, it will have a dramatic positive impact on the lives of people with the disease."
Prof David Bickers, a dermatologist at Columbia University who has treated many patients with the disease, said, "There are few tools in the arsenal for the treatment of alopecia areata that have any demonstrated efficacy.
"This is a major step forward in improving the standard of care for patients suffering from this devastating disease."
The results of the trials, conducted at Columbia University Medical Center, have been published in the journal Nature Medicine.
Until then...geek on!
The Ed.
